[1]姬笑颜 李含笑 杨艳妮 张欣怡 苏明莉 刘西纺△.瑞香素对去卵巢大鼠炎性因子和骨代谢的影响[J].中国中医骨伤科杂志,2021,29(07):17-20.
　JI Xiaoyan LI Hanxiao YANG Yanni ZHANG XinyiSU MingliLIU Xifang.Efficacy of Daphnetin on Inflammatory Factors andBone Metabolism in Ovariectomized Rats[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2021,29(07):17-20.
点击复制

瑞香素对去卵巢大鼠炎性因子和骨代谢的影响()
分享到：

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第29卷
期数:
2021年07期
页码:
17-20
栏目:
实验研究
出版日期:
2021-07-15

文章信息/Info

Title:
Efficacy of Daphnetin on Inflammatory Factors andBone Metabolism in Ovariectomized Rats
文章编号:
1005-0205(2021)07-0017-04
作者:
姬笑颜1 李含笑1 杨艳妮1 张欣怡1 苏明莉2 刘西纺1; 3△
1陕西中医药大学第一临床医学院(陕西 咸阳,712046)2西安体育学院3西安交通大学附属红会医院神经脊柱康复病区
Author(s):
JI Xiaoyan1 LI Hanxiao1 YANG Yanni1 ZHANG Xinyi1SU Mingli2LIU Xifang1; 3△
1The First Clinical Medical College, Shaanxi University of Chinese Medicine, Xianyang 712046, Shaanxi China; 2Xi’an University of Physical Education, Xi’an 710054,China; 3Department of Neurospinal Rehabilitation, Red Society Hospital Affiliated to Xi’an Jiaotong University, Xi’an 710054,China.
关键词:
瑞香素;  骨质疏松症;  白介素-6;  肿瘤坏死因子-α;  钙;  磷;  碱性磷酸酶
Keywords:
daphne;  osteoporosis;  interleukin 6(IL-6);  tumor necrosis factor-α(TNF-α);  calcium(Ca);  phosphorus(P);  alkaline phosphatase(ALP)
分类号:
R-33
文献标志码:
A
摘要:
目的:探讨瑞香素对去卵巢大鼠炎性因子和骨代谢指标的影响。方法:将60只3个月龄SD雌性大鼠随机分为低、中、高剂量组,对照组、模型组、空白组,每组10只。低、中、高剂量组分别予以瑞香素0.275、 0.463、0.668 mg/kg灌胃,1次/d; 对照组阿仑膦酸钠剂量0.630 mg/kg,1次/周; 模型组0.9%生理盐水0.668 mg/kg灌胃; 空白组不干预; 连续给药12周,12周后生化法检测血清钙(Ca)、磷(P)、碱性磷酸酶(ALP),ELISA法检测白介素-6(IL-6)及肿瘤坏死因子-䥺SymbolaA@(TNF-䥺SymbolaA@)的水平; 治疗前后运用双能X线法测全身骨密度(BMD)。结果:治疗前空白组大鼠BMD高于其他各组,差异有统计学意义(P<0.05); 治疗后高剂量组和对照组大鼠的BMD均高于模型组,差异有统计学意义(P<0.05)。低剂量组、高剂量组和空白组IL-6含量均低于模型组,差异有统计学意义(P<0.05); 低剂量组、高剂量组和对照组和空白组TNF-α的含量均低于模型组,差异有统计学意义(P<0.05)。高剂量组Ca含量高于对照组和模型组。低剂量组、高剂量组P含量均高于模型组,差异有统计学意义(P<0.05)。中剂量组、高剂量组、对照组ALP含量均低于模型组,差异有统计学意义(P<0.05)。结论:瑞香素高剂量能够提高绝经后骨质疏松大鼠的BMD,降低IL-6和TNF-䥺SymbolaA@的水平,发挥抗炎作用; 提高绝经后骨质疏松大鼠Ca和P的含量,降低ALP的含量,改善骨代谢。瑞香素可改善去卵巢骨质疏松大鼠的骨痛,增加骨密度和改善骨代谢,对骨质疏松症起治疗作用。
Abstract:
To investigate the efficacies of daphnetin on inflammatory factors and bone metabolism in ovariectomized rats.Methods: 60 three-month-old SD rats were randomly divided into low, medium and high dose groups, control group, model group and blank group, with 10 rats in each group.Low, medium and high dose groups were given daphnetin 0.275, 0.463 and 0.668 mg/kg by gavage, respectively.Once a day.The dose of Allen phosphonic acid sodium in control group was 0.630 mg/kg.Once a week.The model group was given 0.9% saline 0.668 mg/kg by gavage.The blank group was not intervened.All groups were administered continuously for 12 weeks.After 12 weeks, serum calcium(Ca), phosphorus(P), alkaline phosphatase(ALP)was detected by the biochemical method to detect.Interleukin 6(IL-6), tumor necrosis factor-α(TNF-α)level were detected by ELISA method.Total bone mass density(BMD)was measured by double energy X method before and after treatment.Results: Before treatment, BMD of rats in the blank group was higher than that of other groups(P<0.05).After treatment, BMD of rats in each group was higher than that of the model group(P<0.05).After administration, the BMD of rats in the high-dose group and the control group was higher than before administration.The IL-6 content in the low dose, high dose and blank group was lower than that in the model group(P<0.05).The levels of TNF-α in the low dose, high dose, control group and blank group were all lower than those in the model group(P<0.05).The Ca content in the high-dose group was higher than that in the control group and the model group.The P content in the low dose group and the high dose group was higher than that in the model group(P<0.05).The ALP content of medium dose group, high dose group and control group was lower than that of model group(P<0.05).Conclusion: High doses of daphnetin can increase BMD in postmenopausal osteoporosis rats, reduce the level of IL-6 and TNF-α to play a role of anti-inflammatory, enhance the content of Ca and P in postmenopausal osteoporosis rats, reduce the content of ALP to improve bone metabolism.Daphnetin can improve bone pain, increase bone density and improve bone metabolism in ovariectomized osteoporosis rats, and play a therapeutic role in osteoporosis.

参考文献/References:

[1] 夏维波,章振林,林华,等.原发性骨质疏松症诊疗指南(2017)[J].中国骨质疏松杂志,2019,25(3):281-309.
[2] 常志芳,冯成龙,史晓霞,等.免疫与骨质疏松的研究进展[J].中国骨质疏松杂志,2015,21(4):508-513.
[3] 夏婷,李双庆.炎症相关骨质疏松症的发病机制[J].中国骨质疏松杂志,2015,21(1):117-120.
[4] 程千,刘起富,金铭,等.绝经后女性铁蓄积与骨代谢及机体炎症反应的相关性研究[J].中国骨质疏松杂志,2019,25(5):649-655.
[5] FANG H,ZHANG H,WANG Z,et al.Systemic immune-inflammation index acts as a novel diagnostic biomarker for postmenopausal osteoporosis and could predict the risk of osteoporotic fracture[J].J Clin Lab Anal,2020,34(1):e23016.
[6] 郑茂,邹玉,傅颖媛.瑞香素药理作用的研究进展[J].中成药,2017,39(4):790-794.
[7] LIU X,GAO X,LIU Y,et al.Daphnetin inhibits RANKL-induced osteoclastogenesis in vitro[J].J Cell Biochem,2018.doi:10.1002/jcb.27555.
[8] 申宁,席晓云,李飞,等.瑞香素联合IGF-1对大鼠脂肪间充质干细胞成软骨分化的影响[J].中国修复重建外科杂志,2019,33(6):743-749.
[9] 李静,王东亮,衣蕾,等.瑞香素抑制c-Jun氨基末端激酶/核因子κB(JNK/NF-κB)通路减轻大鼠心肌缺血损伤[J].细胞与分子免疫学杂志,2020,36(6):513-519.
[10] ZHANG L,GU Y,LI H,et al.Daphnetin protects against cisplatin-induced nephrotoxicity by inhibiting inflammatory and oxidative response[J].Int Immunopharmacol,2018,65:402-407.
[11] ZHI J,DUAN B,PEI J,et al.Daphnetin protects hippocampal neurons from oxygen-glucose deprivation-induced injury[J].J Cell Biochem,2019,120(3):4132-4139.
[12] WANG G,PANG J,HU X,et al.Daphnetin:a novel anti-helicobacter pylori agent[J].Int J Mol Sci,2019,20(4):850-859.
[13] GANJI R,MOGHBELI M,SADEGHI R,et al.Prevalence of osteoporosis and osteopenia in men and premenopausal women with celiac disease:a systematic review[J].Nutr J,2019,18(1):9-15.
[14] CATALANO A, LODDO S, BELLONE,et al.Pulsed electromagnetic fields modulate bone metabolism via RANKL/OPG and Wnt/β-catenin pathways in women with postmenopausal osteoporosis:a pilot study[J].Bone,2018,116:42-46.
[15] 林思文,王丽丽,施剑明,等.骨髓间充质干细胞成骨分化中信号转导途径与雌激素受体的关系[J].中国老年学杂志,2016,36(5):1267-1270.
[16] 严正杰,戴有金,侯道荣.白介素-10对去卵巢小鼠骨质疏松的作用[J].中国医药导报,2017,14(10):39-42.
[17] ISLANDER U, JOCHEMS C, LAGERQUIST M K,et al.Estrogens in rheumatoid arthritis:the immune system and bone[J].Mol Cell Endocrinol,2011,335(1):14-29.
[18] YU H, HERBERT B A, VALERIO M,et al.FTY720 inhibited proinflammatory cytokine release and osteoclastogenesis induced by aggregatibacter actinomycetemcomitans[J].Lipids Health Dis,2015,14:66-73.
[19] 陈柏龄,黎艺强,谢登辉.TNF-α在骨质疏松性疼痛中的作用[J].中国病理生理杂志,2010,26(10):1931-1935.
[20] 陈鹏,李杨,胡伟文,等.绝经后骨质疏松症TNF-α通过激活NF-κB促进RANKL诱导的破骨细胞形成[J].基因组学与应用生物学,2019,38(2):960-965.
[21] 代婵,王洁莹,邓慧敏,等.瑞香素在TNF-α诱导的CIA大鼠成纤维样滑膜细胞NF-κB信号通路中的抑炎作用[J].时珍国医国药,2018,29(1):20-24.
[22] 何荣安,莫文飞,连冬丽,等.瑞香素对TNF-α刺激的HaCaT角质形成细胞炎症因子表达的影响[J].世界最新医学信息文摘,2019,19(37):211-213.
[23] 张萌萌,张秀珍,邓伟民,等.骨代谢生化指标临床应用专家共识(2020)[J].中国骨质疏松杂志,2020,26(6):781-796.
[24] 杨锋,孙玉华,刘佃滨,等.骨质疏松患者骨碱性磷酸酶、钙、磷代谢变化及与牙槽骨骨密度的相关性[J].中国骨质疏松杂志,2017,23(9):1160-1166.
[25] 谌红珊,胡藩,刘冬梅,等.中老年人群骨密度与血钙、血磷、骨转换指标的关系[J].中国老年学杂志,2017,37(2):380-382.

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(31670954)西安市卫生健康委员会一般研究项目(2020yb33)陕西中医药大学校级课题重点项目(2020CX12)
△通信作者 E-mail:lxfyg2006@126.com
更新日期/Last Update: 2021-07-15